Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
CVS Health Co. stock logo
CVS
CVS Health
$67.79
+1.0%
$62.42
$43.56
$79.98
$85.46B0.5411.55 million shs7.46 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$165.89
+1.3%
$159.06
$140.68
$169.99
$394.52B0.477.62 million shs12.46 million shs
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
CVS Health Co. stock logo
CVS
CVS Health
+0.98%+0.36%+2.94%+51.00%-15.01%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
+1.38%+1.51%+0.40%+14.70%+4.87%
Remove Ads
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
CVS Health Co. stock logo
CVS
CVS Health
4.9068 of 5 stars
2.54.03.33.92.93.33.1
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.4047 of 5 stars
2.33.04.23.93.52.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
CVS Health Co. stock logo
CVS
CVS Health
2.90
Moderate Buy$70.413.87% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.56
Moderate Buy$171.333.28% Upside

Current Analyst Ratings Breakdown

Latest CVS and JNJ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/21/2025
CVS Health Co. stock logo
CVS
CVS Health
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$72.00 ➝ $74.00
3/10/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral
3/5/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$159.00 ➝ $171.00
2/19/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$181.00 ➝ $181.00
2/18/2025
CVS Health Co. stock logo
CVS
CVS Health
Argus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$77.00
2/18/2025
CVS Health Co. stock logo
CVS
CVS Health
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$80.00 ➝ $81.00
2/13/2025
CVS Health Co. stock logo
CVS
CVS Health
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$68.00 ➝ $73.00
2/13/2025
CVS Health Co. stock logo
CVS
CVS Health
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$60.00 ➝ $76.00
2/13/2025
CVS Health Co. stock logo
CVS
CVS Health
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$71.00 ➝ $73.00
2/13/2025
CVS Health Co. stock logo
CVS
CVS Health
Leerink Partners
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$55.00 ➝ $75.00
2/12/2025
CVS Health Co. stock logo
CVS
CVS Health
Leerink Partnrs
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
(Data available from 4/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
CVS Health Co. stock logo
CVS
CVS Health
$372.81B0.23$9.47 per share7.16$60.06 per share1.13
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$88.82B4.50$13.63 per share12.17$29.69 per share5.59
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
CVS Health Co. stock logo
CVS
CVS Health
$4.61B$3.6618.5210.010.981.24%9.11%2.71%4/29/2025 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$14.07B$6.6524.9514.992.5618.20%34.24%13.63%4/15/2025 (Estimated)

Latest CVS and JNJ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/15/2025N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.59N/AN/AN/A$21.65 billionN/A
2/12/2025Q4 2024
CVS Health Co. stock logo
CVS
CVS Health
$0.89$1.19+$0.30$1.30$96.90 billionN/A
1/22/2025Q4 2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$1.99$2.04+$0.05$1.41$22.44 billion$22.52 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
CVS Health Co. stock logo
CVS
CVS Health
$2.663.92%+9.97%72.68%N/A
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.962.99%+5.43%74.59%63 Years

Latest CVS and JNJ Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/20/2025
CVS Health Co. stock logo
CVS
CVS Health
quarterly$0.66503.89%4/22/20254/22/20255/1/2025
1/2/2025
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.43%2/18/20252/18/20253/4/2025
1/3/2025
CVS Health Co. stock logo
CVS
CVS Health
quarterly$0.66506.02%1/23/20251/23/20252/3/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
CVS Health Co. stock logo
CVS
CVS Health
0.80
0.81
0.60
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.43
1.11
0.86

Institutional Ownership

CompanyInstitutional Ownership
CVS Health Co. stock logo
CVS
CVS Health
80.66%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
CVS Health Co. stock logo
CVS
CVS Health
0.24%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%
CompanyEmployeesShares OutstandingFree FloatOptionable
CVS Health Co. stock logo
CVS
CVS Health
300,0001.26 billion1.26 billionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
152,7002.41 billion2.40 billionOptionable

Recent News About These Companies

TD Cowen Reaffirms Their Buy Rating on Johnson & Johnson (JNJ)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
CVS Health stock logo

CVS Health NYSE:CVS

$67.79 +0.65 (+0.96%)
Closing price 03/31/2025 03:59 PM Eastern
Extended Trading
$67.83 +0.04 (+0.06%)
As of 08:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical, disease management, and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, CMS, plans offered on public health insurance, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, LTC pharmacies and on-site pharmacies, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was incorporated in 1996 and is headquartered in Woonsocket, Rhode Island.

Johnson & Johnson stock logo

Johnson & Johnson NYSE:JNJ

$165.89 +2.18 (+1.33%)
Closing price 03/31/2025 03:59 PM Eastern
Extended Trading
$159.69 -6.19 (-3.73%)
As of 08:54 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.